Home rein asia
Newsletter
Free trial
Subscribe
Home rein asia

Emerging risks | Growth Opportunities | APAC Insurance

Home rein asia
Thursday, April 23, 2026

Dedicated hubs

Life and Health
LifeandHealth_Menuwebp
Cyber
Cyber_Menuwebp
Marine
MarineMenuwebp
Specialty
SpecialtyMenu
Reinsurance
ReinsuranceMenu
Brokers
Brokers
Capital management
CapitalMenu
Regulation
RegulationMenuwebp
Nat cat
NatCatMenu

Browse content

AXA, China Biotech Services sign MoU to explore cancer treatment option for policyholders

Partnership aims to bring together AXA’s insurance expertise and China Biotech Services’ focus on precision diagnostics and therapeutics.
Axa china biotech services sign mou to explore cancer treatment option for policyholders rein asia

Reih Angeles

Members only
Unlock this story now.
Free trial - no credit card required.
• Unlimited access to breaking news and analysis
• Daily briefings from across the Asia Pacific market
• Exclusive interviews and in-depth reports
1 week trial - step 1
Already a member?
Sign in here

Share this article

Read next

FlagsOfTheUnitedStatesIsraelAndIranOnWooden
talent-crunch-intensifies-as-asias-transactional-risk-market-matures
equity-push-fuels-china-life-insurers-2025-investment-gains
benign-catastrophe-year-investment-gains-lift-australia-non-life-profit-to-a10-5bn-am-best
asia-life-reinsurance-capital-up-29-as-global-capacity-tops-us160bn-guy-carpenter
fitch-sees-limited-near-term-credit-impact-as-apac-updates-capital-and-fx-rules
hdfc-life-vnb-growth-tapers-in-fy2026-amid-steady-premium-growth
aon-projects-strong-rebound-ahead-for-lloyds-legacy-market-amid-tightened-capital-discipline
australian-general-insurer-complaints-rise-30-in-fy2025-asic-data-shows
malaysia-life-insurers-medical-claims-rise-5-3-to-rm9-37bn-in-2025-liam